CAS RN: 1823339-95-2
Pyrido[3,2-f]-1,4-oxazepin-5(2H)-one, 7-bromo-3,4-dihydro-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260130
100mg / 250mg / 500mg
Out of stock
1 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1823339-95-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1823339-95-2 / 7-bromo-3,4-dihydro-2H-pyrido[3,2-f][1,4]oxazepin-5-one
Standard CAS: 1823339-95-2
Multi CAS: No
Basic Information
copy
CAS
1823339-95-2 copy
Multi CAS
No copy
Molecular Formula
C8H7BrN2O2 copy
Molecular Weight
243.060000 copy
Exact Mass
241.969090 copy
SMILES
C1COC2=C(C=C(C=N2)Br)C(=O)N1 copy
InChI
InChI=1S/C8H7BrN2O2/c9-5-3-6-7(12)10-1-2-13-8(6)11-4-5/h3-4H,1-2H2,(H,10,12) copy
InChIKey
YTARKWINAIOMJV-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.25 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
49.77 copy
TPSA
51.22 copy
LogP / Solubility
WLOGP
0.97 copy
MLOGP
0.86 copy
XLogP3
0.9 copy
Consensus LogP
0.91 copy
Log S (ESOL)
-2.3 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.25 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.04 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.52 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy